Hap Trading, LLC Mesoblast LTD Call Options Transaction History

Hap Trading, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 12, 2022	SELL	$3.58 - $4.98 $59,070 - $82,170	-16,500 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$4.17 - $7.09 $9,174 - $15,598	-2,200 Reduced 11.76%	16,500 $1,000
Q3 2021 Nov 10, 2021	BUY	$5.87 - $7.85 $109,769 - $146,795	18,700 New	18,700 $13,000
Q1 2021 May 14, 2021	SELL	$8.26 - $11.4 $83,426 - $115,140	-10,100 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$8.21 - $18.59 $48,439 - $109,681	-5,900 Reduced 36.88%	10,100 $3,000
Q3 2020 Nov 13, 2020	BUY	$11.33 - $19.81 $181,280 - $316,960	16,000 New	16,000 $76,000

151K

Ticker MESO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 147,316,000
Market Cap $1.2B
Description
Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its ...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.